The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males
Clinical trial NCT04347005 · COMPLETED
Trial details
- NCT number
- NCT04347005
- Sponsor
- Arthrosi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2019-07-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.